Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating adjuvant atezolizumab or placebo with trastuzumab emtansine in HER2-positive breast cancer at high risk of recurrence after …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Kadcyla (ado-trastuzumab emtansine)
• Tecentriq (atezolizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING